YW8-30408-93184
4 vaccinations
3 coded responses
26 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 900 / CA
- Registered
- 2021-05-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Dose 1 — Moderna
-
2021-05-14
Registered in v-safe
-
2021-05-14
Dose 2 — Moderna
-
2021-05-14
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Itching · Fatigue or tirednessAdult check-in
-
2021-05-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-17
- 2021-05-18
- 2021-05-19
- 2021-05-20
- 2021-05-23
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
-
2021-06-25
Survey response — day 42, dose 2MedDRA: Paranasal sinus discomfort — Feeling: GoodFree text: Ongoing sinus pressure, no pain, thoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-14
-
2021-12-09
Dose 3 — Moderna
-
2022-05-16
Survey response — 12 months, dose 2MedDRA: Lymphadenopathy — Feeling: FairFree text: Enlarged lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2022-09-19
Dose 4 — Moderna
-
2022-09-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
-
2022-09-21
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-22
- 2022-09-23
- 2022-09-26
- 2022-10-03
- 2022-10-19
- 2022-10-27
- 2022-10-31
- 2022-12-21
-
2023-03-20
Survey response — 6 months, dose 4MedDRA: Arthralgia, Cough, Myalgia, Nasal congestion, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-20
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Moderna | |
| 2 | 2021-05-14 | Moderna | |
| 3 | 2021-12-09 | Moderna | No |
| 4 | 2022-09-19 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-20 | Unsuccessful |
Free text
Release 9 — day 42, dose 2
Symptoms: Ongoing sinus pressure, no pain, though
Release 11 — 12 months, dose 2
Symptoms: Enlarged lymph node
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release